Logo image of EH

EHANG HOLDINGS LTD-SPS ADR (EH) Stock Fundamental Analysis

NASDAQ:EH - Nasdaq - US26853E1029 - ADR - Currency: USD

19.58  +0.8 (+4.26%)

Fundamental Rating

5

Taking everything into account, EH scores 5 out of 10 in our fundamental rating. EH was compared to 67 industry peers in the Aerospace & Defense industry. No worries on liquidiy or solvency for EH as it has an excellent financial health rating, but there are worries on the profitability. EH is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year EH was profitable.
EH had a positive operating cash flow in the past year.
In the past 5 years EH always reported negative net income.
EH had negative operating cash flow in 4 of the past 5 years.
EH Yearly Net Income VS EBIT VS OCF VS FCFEH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -14.54%, EH is not doing good in the industry: 71.64% of the companies in the same industry are doing better.
EH's Return On Equity of -24.09% is on the low side compared to the rest of the industry. EH is outperformed by 67.16% of its industry peers.
Industry RankSector Rank
ROA -14.54%
ROE -24.09%
ROIC N/A
ROA(3y)-42.25%
ROA(5y)-40.69%
ROE(3y)-143.11%
ROE(5y)-111.08%
ROIC(3y)N/A
ROIC(5y)N/A
EH Yearly ROA, ROE, ROICEH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

With an excellent Gross Margin value of 61.26%, EH belongs to the best of the industry, outperforming 95.52% of the companies in the same industry.
EH's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for EH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.07%
GM growth 5Y0.99%
EH Yearly Profit, Operating, Gross MarginsEH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

8

2. Health

2.1 Basic Checks

EH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EH has more shares outstanding
EH has more shares outstanding than it did 5 years ago.
EH has a better debt/assets ratio than last year.
EH Yearly Shares OutstandingEH Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EH Yearly Total Debt VS Total AssetsEH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 7.93 indicates that EH is not in any danger for bankruptcy at the moment.
EH has a better Altman-Z score (7.93) than 77.61% of its industry peers.
The Debt to FCF ratio of EH is 0.81, which is an excellent value as it means it would take EH, only 0.81 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EH (0.81) is better than 97.01% of its industry peers.
EH has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of EH (0.09) is better than 80.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.81
Altman-Z 7.93
ROIC/WACCN/A
WACC8.86%
EH Yearly LT Debt VS Equity VS FCFEH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.89 indicates that EH has no problem at all paying its short term obligations.
EH has a Current ratio of 2.89. This is in the better half of the industry: EH outperforms 65.67% of its industry peers.
EH has a Quick Ratio of 2.73. This indicates that EH is financially healthy and has no problem in meeting its short term obligations.
EH has a Quick ratio of 2.73. This is amongst the best in the industry. EH outperforms 83.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 2.73
EH Yearly Current Assets VS Current LiabilitesEH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

8

3. Growth

3.1 Past

EH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.05%, which is quite impressive.
EH shows a strong growth in Revenue. In the last year, the Revenue has grown by 288.33%.
Measured over the past years, EH shows a very strong growth in Revenue. The Revenue has been growing by 30.21% on average per year.
EPS 1Y (TTM)31.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2000%
Revenue 1Y (TTM)288.33%
Revenue growth 3Y100.23%
Revenue growth 5Y30.21%
Sales Q2Q%205.21%

3.2 Future

The Earnings Per Share is expected to grow by 71.43% on average over the next years. This is a very strong growth
EH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 49.73% yearly.
EPS Next Y-313.81%
EPS Next 2Y45.51%
EPS Next 3Y84.85%
EPS Next 5Y71.43%
Revenue Next Year107.76%
Revenue Next 2Y82.13%
Revenue Next 3Y65.82%
Revenue Next 5Y49.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EH Yearly Revenue VS EstimatesEH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
EH Yearly EPS VS EstimatesEH Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 489.50, which means the current valuation is very expensive for EH.
Based on the Price/Earnings ratio, EH is valued a bit more expensive than the industry average as 64.18% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of EH to the average of the S&P500 Index (27.54), we can say EH is valued expensively.
A Price/Forward Earnings ratio of 92.89 indicates a quite expensive valuation of EH.
EH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. EH is more expensive than 65.67% of the companies in the same industry.
EH's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 489.5
Fwd PE 92.89
EH Price Earnings VS Forward Price EarningsEH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

EH's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 85.74
EV/EBITDA N/A
EH Per share dataEH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as EH's earnings are expected to grow with 84.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.51%
EPS Next 3Y84.85%

More info and screens

0

5. Dividend

5.1 Amount

EH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EHANG HOLDINGS LTD-SPS ADR

NASDAQ:EH (7/21/2025, 11:41:09 AM)

19.58

+0.8 (+4.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-26 2025-05-26/bmo
Earnings (Next)08-20 2025-08-20
Inst Owners33.03%
Inst Owner Change-1.06%
Ins Owners0.64%
Ins Owner ChangeN/A
Market Cap1.41B
Analysts85.26
Price Target26.78 (36.77%)
Short Float %23.03%
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.81%
Min EPS beat(2)126.03%
Max EPS beat(2)195.58%
EPS beat(4)4
Avg EPS beat(4)125.28%
Min EPS beat(4)77.82%
Max EPS beat(4)195.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.78%
Min Revenue beat(2)-7.9%
Max Revenue beat(2)9.46%
Revenue beat(4)3
Avg Revenue beat(4)7.7%
Min Revenue beat(4)-7.9%
Max Revenue beat(4)20.82%
Revenue beat(8)6
Avg Revenue beat(8)58.13%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.65%
PT rev (3m)1.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-332.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.16%
Valuation
Industry RankSector Rank
PE 489.5
Fwd PE 92.89
P/S 22.2
P/FCF 85.74
P/OCF 64.03
P/B 10.59
P/tB 10.62
EV/EBITDA N/A
EPS(TTM)0.04
EY0.2%
EPS(NY)0.21
Fwd EY1.08%
FCF(TTM)0.23
FCFY1.17%
OCF(TTM)0.31
OCFY1.56%
SpS0.88
BVpS1.85
TBVpS1.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.54%
ROE -24.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.26%
FCFM 25.89%
ROA(3y)-42.25%
ROA(5y)-40.69%
ROE(3y)-143.11%
ROE(5y)-111.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.07%
GM growth 5Y0.99%
F-Score6
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.81
Debt/EBITDA N/A
Cap/Depr 307.69%
Cap/Sales 8.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.89
Quick Ratio 2.73
Altman-Z 7.93
F-Score6
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)177.12%
Cap/Depr(5y)175.98%
Cap/Sales(3y)15.9%
Cap/Sales(5y)16.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2000%
EPS Next Y-313.81%
EPS Next 2Y45.51%
EPS Next 3Y84.85%
EPS Next 5Y71.43%
Revenue 1Y (TTM)288.33%
Revenue growth 3Y100.23%
Revenue growth 5Y30.21%
Sales Q2Q%205.21%
Revenue Next Year107.76%
Revenue Next 2Y82.13%
Revenue Next 3Y65.82%
Revenue Next 5Y49.73%
EBIT growth 1Y14.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.44%
EBIT Next 3Y56.26%
EBIT Next 5YN/A
FCF growth 1Y221.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y278.71%
OCF growth 3YN/A
OCF growth 5YN/A